By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cambria Biosciences 

MS-008 Brandeis University
415 South Street
Waltham  Massachusetts  02454-9110  U.S.A.
Phone: 781-736-4860 Fax: 781-736-3107



Company News
Cambria Pharmaceuticals Announces $5.4 Million Series A Financing 4/22/2008 7:44:38 AM
Cambria Biosciences' Chemical Genetics Platform is Featured in Nature Article Describing a New Pharmaceutical Mode of Action 3/13/2008 8:45:49 AM
Cambria Biosciences Receives $5.0 Million in Grants and Awards for Neurodegenerative Disease Drug Discovery and Preclinical Development Programs 11/12/2007 11:38:18 AM
Cambria Biosciences Announces Collaboration with Pfizer Animal Health in Antiparasitic Drug Discovery 6/7/2007 12:31:39 PM
Cambria Biosciences Unveils Novel Epilepsy Drug Discovery Program at the Neurotechnology Industry Organization Conference 5/18/2007 2:23:16 AM
Cambria Biosciences Presents New Screening Model For Epilepsy Drug Discovery At Society For Neuroscience Meeting 10/16/2006 11:24:15 AM
Cambria Biosciences' Innovative Technology Yields New Understanding Of Insecticide Mode Of Action 8/7/2006 4:47:35 PM
Cambria Biosciences Awarded Three Small Business Innovation Research Grants From National Institutes of Health (NIH) For Company's Neurodegenerative Disease Program10/19/2005 5:12:41 PM
Cambria Biosciences Announces Milestones In Insecticide Discovery Collaboration With Dow Agrosciences10/19/2005 5:12:26 PM
Cambria Biosciences Announces Discovery Collaboration With Syngenta (SYT)10/19/2005 5:09:00 PM